News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Myeloma Paper of the Day, April 18th, suggested by Robert Orlowski
Apr 18, 2025, 16:18

Myeloma Paper of the Day, April 18th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: German multicenter analysis of talquetamab in 138 patients with RRM finds ORR 65%, median PFS 6.4 months; prior BTCE exposure, ISS stage III, and extraosseous and penta-drug refractory disease associated with unfavorable outcomes.”

“A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma”

Authors: Jan Frenking, Christine Riedhammer, Raphael Teipel, Florian Bassermann, Britta Besemer, Ralph Wäsch, Romans Zukovs, Mathias Hänel, Leo Rasche, Marc Raab et al.

Myeloma Paper of the Day, April 18th, suggested by Robert Orlowski

More posts featuring Robert Orlowski.

Britta Besemer cancer Christine Riedhammer Florian Bassermann Jan Frenking Leo Rasche Marc Raab Mathias Hänel multiple myeloma Myeloma Paper of the Day OncoDaily Oncology Ralph Wäsch Raphael Teipel relapsed/refractory multiple myeloma Robert Orlowski Romans Zukovs RRMM Talquetamab
Special Coverage
Blog
May 9, 2025, 10:04
Aakash Desai: AI in Predicting EGFR Mutations from Whole Slide Images in Lung Cancer
Blog
May 9, 2025, 09:39
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Blog
May 9, 2025, 09:37
Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session
Blog
May 9, 2025, 09:29
ESO - M2ICOS Project Launches Fellowship Program to Support Oncology Training and Mobility in the EU
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic
Science
May 9, 2025, 08:02
Ashish Kamat: Predictive Value of AI Histologic Biomarker CHAI in NMIBC Treatment
Drugs
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic
Science
May 9, 2025, 07:24
Elizabeth McKenna: Study on Early- and Older-Onset Cancer Trends in the U.S. by Meredith Shiels and colleagues